Rain Med develops robotic systems for vascular interventional surgery, specifically focusing on coronary angiography. Their technology enhances precision in catheter navigation, reducing procedural risks and improving patient outcomes in cardiac interventions.
Funding
$100M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Vascular interventional surgery, such as coronary angiography, relies on manual catheter navigation, which can be challenging and may lead to procedural risks due to limited precision. Current methods may not always provide optimal visualization and control during these delicate interventions.
Solution
Rain Med is developing robotic systems designed to enhance precision and control in vascular interventional surgery, particularly for coronary angiography. Their technology aims to improve catheter navigation, offering surgeons greater accuracy and stability during procedures. By leveraging robotics, Rain Med seeks to minimize procedural risks, optimize visualization, and ultimately improve patient outcomes in cardiac interventions. The system is intended to provide a more controlled and precise approach to navigating complex vascular structures.
Target Audience
The primary target audience includes interventional cardiologists, vascular surgeons, and hospitals performing coronary angiography and other vascular interventions.
Features
- Robotic-assisted catheter navigation for enhanced precision
- Improved visualization capabilities during vascular procedures
- Enhanced control and stability for surgeons
- Reduced procedural risks associated with manual navigation